SE8302345D0 - PLEUROMUTILIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS - Google Patents

PLEUROMUTILIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS

Info

Publication number
SE8302345D0
SE8302345D0 SE8302345A SE8302345A SE8302345D0 SE 8302345 D0 SE8302345 D0 SE 8302345D0 SE 8302345 A SE8302345 A SE 8302345A SE 8302345 A SE8302345 A SE 8302345A SE 8302345 D0 SE8302345 D0 SE 8302345D0
Authority
SE
Sweden
Prior art keywords
alkylamino
pharmaceuticals
processes
production
unsubstituted
Prior art date
Application number
SE8302345A
Other languages
Swedish (sv)
Other versions
SE8302345L (en
Inventor
H Berner
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8302345D0 publication Critical patent/SE8302345D0/en
Publication of SE8302345L publication Critical patent/SE8302345L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of formula I <IMAGE> wherein R1 represents ethyl or vinyl, R2 represents lower alkoxy, amino, lower alkylamino which may be unsubstituted or substituted by amino, lower alkylamino, di-(lower)-alkylamino or hydroxy, di-(lower)-alkylamino or a five or six membered, saturated heterocycle which contains one or two nitrogens as heteroatoms and which may be unsubstituted or substituted by lower alkyl and R3 and R4 represent, independently, hydrogen or lower alkyl, in free base o; acid addition or quaternary salt form, exhibit pharmacological activity, particularly against bacteria and obligatory anaerobes, and can be incorporated into chemotherapeutic compositions.
SE8302345A 1982-04-28 1983-04-26 PLEUROMUTILIN DERIVATIVES, THE PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINAL PRODUCT SE8302345L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT165182 1982-04-28
AT427082 1982-11-24

Publications (2)

Publication Number Publication Date
SE8302345D0 true SE8302345D0 (en) 1983-04-26
SE8302345L SE8302345L (en) 1983-10-29

Family

ID=25596422

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8302345A SE8302345L (en) 1982-04-28 1983-04-26 PLEUROMUTILIN DERIVATIVES, THE PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINAL PRODUCT

Country Status (12)

Country Link
AU (1) AU1393783A (en)
DE (1) DE3314479A1 (en)
DK (1) DK185683A (en)
ES (1) ES521847A0 (en)
FI (1) FI831367L (en)
FR (1) FR2526019A1 (en)
GB (1) GB2121035A (en)
IL (1) IL68508A0 (en)
IT (1) IT1197634B (en)
NL (1) NL8301448A (en)
PT (1) PT76598B (en)
SE (1) SE8302345L (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153277B1 (en) * 1984-02-17 1987-08-26 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
GB0218578D0 (en) 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
CN104447450B (en) * 2014-07-08 2016-09-28 南通大学 Cysteine amide-type pleuromutilin derivative and preparation method and medical usage
CN104961666B (en) * 2014-07-08 2017-04-12 南通大学 2-mercaptoacetamide pleuromutilin derivatives, and preparation method and medical application thereof
CN109384698B (en) * 2017-08-04 2022-07-08 保定加合精细化工有限公司 Preparation method of diterpene antibiotic for livestock and poultry

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT301752B (en) * 1969-07-21 1972-09-25 Biochemie Gmbh Process for the preparation of new pleuromutilin derivatives
US3919290A (en) * 1972-10-03 1975-11-11 Sandoz Ltd Substituted 14-desoxy-mutilins
IE44428B1 (en) * 1975-09-30 1981-12-02 Squibb & Sons Inc New derivatives of pleuromutilin and compositions containig same
DE2823712C2 (en) * 1978-05-31 1987-04-09 Sandoz-Patent-GmbH, 7850 Lörrach Process for the preparation of pleuromutilin derivatives

Also Published As

Publication number Publication date
SE8302345L (en) 1983-10-29
FR2526019B1 (en) 1985-04-26
IT1197634B (en) 1988-12-06
IL68508A0 (en) 1983-07-31
NL8301448A (en) 1983-11-16
DK185683A (en) 1983-10-29
ES8406431A1 (en) 1984-08-01
PT76598A (en) 1983-05-01
DK185683D0 (en) 1983-04-26
AU1393783A (en) 1983-11-03
FI831367A0 (en) 1983-04-21
DE3314479A1 (en) 1983-11-03
ES521847A0 (en) 1984-08-01
FR2526019A1 (en) 1983-11-04
GB2121035A (en) 1983-12-14
IT8348162A0 (en) 1983-04-27
FI831367L (en) 1983-10-29
GB8311194D0 (en) 1983-06-02
PT76598B (en) 1986-01-24

Similar Documents

Publication Publication Date Title
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
ES2054826T3 (en) PEPTIDES WITH COLAGENASA INHIBITING ACTIVITY.
ES8606262A1 (en) Pleuromutilin derivatives, process for their preparation and their use.
ES479820A1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
SE8302345D0 (en) PLEUROMUTILIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS
ES400963A1 (en) 3-benzylpyridines
GB8531160D0 (en) Organic compounds
ES8504815A1 (en) Penem derivatives, and composition containing them
ES478691A1 (en) Bis-triazinylaminostilbene compounds and their use as fluorescent brightening agents
DE3460467D1 (en) Hydroquinone derivatives and production thereof
ES8503347A1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them.
GB1090283A (en) (2-aminoethyl)-hydroquinones
SE7407129L (en)
ES2094132T3 (en) USE OF XANTINA DERIVATIVES AGAINST ULCERA PEPTICA.
ES8200142A1 (en) Optically active cephalosporin analogs, process for their preparation and their use.
GB1218590A (en) N-substituted piperidine spiro compounds
IL67464A (en) N,n-disubstituted alkenamides and phenylalkenamides,their production and pharmaceutical compositions containing them
GB1065125A (en) Dichloroacetamido propanediol derivatives
DE3679257D1 (en) 4-CYANOPIPERIDINE DERIVATIVES, PRODUCTION AND USE.
GB1076867A (en) Improvements in or relating to 2,4-diamino-6-substituted pyrimidines
GB1108918A (en) 2-imidazolidone derivatives
GB1017450A (en) 2-amino-4-alkoxy-úË-triazines
GB1000807A (en) 3,4,5-trimethoxybenzohydroxamic acid and salts thereof
GB1199040A (en) Diisoeugenol Derivatives
GB1025160A (en) Quaternary benzylammonium salts and their production

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8302345-7

Format of ref document f/p: F